Knoxville was recently named the THIRD worst city for people with fall allergies, and this fall will be one of the toughest. In addition to the usual symptoms – sneezing, watery eyes, runny nose – fall allergies can also trigger asthma attacks. So how can you enjoy the outdoors AND keep your asthma in control? iSonea’s AsthmaSenseapp might be the answer.
AsthmaSense alerts users when their asthma is out of control. Asthmatics input their medication, symptoms and breathing test results into the app. AsthmaSense then analyzes the data and compares it against the National Institute of Health guidelines – alerting the user if their asthma is not well controlled. Users can also set medication reminders. All of this data is stored, giving the user and their doctor a better picture of their lung health.
Medical technology company iSonea Ltd. (ASX: ISN; OTCQX: ISOAD) has introduced an asthma management smartphone app, AsthmaSense™ v.1.0.1.
AsthmaSense™ v.1.0.1 is available for free for iPhone, iPad and Android users. According to the American Lung Association, more than seven million children suffer from asthma, making it one of the most chronic childhood disorders in the United States. Asthma is a leading cause of school absenteeism, accounting for more than 14 million lost school days.
With AsthmaSense, parents and children have the most intelligent asthma management app at their fingertips. Unlike most health apps which act as passive journals, AsthmaSense v.1.0.1 analyzes user symptoms, medication usage and lung function measurements against the National Institute of Health (NIH) asthma guidelines, alerting the user if it senses that their asthma is not well controlled.
With AsthmaSense, users can input their medication, symptoms and peak flow results, and set alerts for medication and lung function testing. In addition to using this information to determine the status of a user’s asthma, the AsthmaSense app stores this data, giving the user and their doctor a better picture of their lung health.
“Autumn is a tough time for asthmatics, especially children. By offering AsthmaSense for free through September, we are increasing access to the most intelligent, easy-to-use asthma management app on the market during this troublesome season,” said Michael Thomas, CEO of iSonea Ltd. “At iSonea, we are committed to helping asthmatics breathe easier and we are continuing to develop tools to help people control this disease.”
AsthmaSense is the first of iSonea’s family of asthma management apps. Future iSonea apps will incorporate the Company’s proprietary Acoustic Respiratory Monitoring (ARM™) technology and diagnostic algorithms. The company is also developing the AsthmaSense Cloud™ for data sharing and enhanced capabilities for detecting asthma risk based on changes in environmental conditions such as air quality and weather.
AsthmaSense is available for free on the Apple App Store (for iPhone and iPad users), Google Play and Amazon App Stores (for Android users).
To see how one mother uses iSonea’s technology to keep her son’s asthma under control, please follow this link.
iSonea Limited (ASX: ISN; OTCQX: ISOAD) is an emerging medical technology company developing innovative, non-invasive devices and mobile health apps to improve the management of chronic, costly respiratory disorders such as asthma and COPD. By leveraging iSonea’s proprietary Acoustic Respiratory Monitoring™ (ARM) technology with its AsthmaSense™ mobile applications, iSonea is turning smartphones into medical devices, enabling anyone, anywhere, at any time to monitor breathing distress symptoms, in order to take action. iSonea’s ARM devices have been cleared for use by the U.S. Food and Drug Administration, the Australian TGA and the European Union CE. For more information, please visit www.SoundAsthma.com.